Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
1 raison identifiée
Référence presse grand public
Cité 10 fois dans les médias — pédagogie reconnue
✨ Génération du profil synthétique IA en cours…
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
6
6 articles ont été cités au moins 6fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
h-index
Total citations reçues
187
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
28
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
3
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Extending dataflows with temporal graphs
2017Congrès43rd International Computer Music Conference 2017
Exécution répartie de scénarios interactifs
2017CongrèsJournées d’Informatique Musicale
Graphical Temporal Structured Programming for Interactive Music
2016CongrèsInternational Computer Music Conference
Rethinking the audio workstation: tree-based sequencing with i-score and the LibAudioStream
2016CongrèsSound and Music Computing Conference
Outils d'écriture spatiale pour les partitions interactives
2016CongrèsJournées d'informatique musicale 2016
OSSIA: Towards a unified interface for scoring time and interaction
2015CongrèsTENOR 2015 - First International Conference on Technologies for Music Notation and Representation
Solids removal at a recirculating salmon-smolt farm
2009ArticleAquacultural Engineering
VIRAGE : UNE REFLEXION PLURIDISCIPLINAIRE AUTOUR DU TEMPS DANS LA CREATION NUMERIQUE
2009CongrèsJournées d'Informatique Musicale
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Source : Google News (recherche par nom complet — homonymes possibles, vérifier le contenu).
📰 ladepeche.fr · 25/03/2026
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxPdTdHRTFIVXhJWTNVaWZ6ZXZ6UXRzSmV3eFRUX1ZNQm9lZjViLXE0ZFhUMU96ZUlVYjRTVkJJdllMd3hsU1Q2Ql9qbVR5TjQyMFFTRzdKeDhHazZITWZtbkoxdFVDQy1yQ1NkQ0J2MFdwaGJLWHFMNUtpVVRKOUhkQ3RmNkVBcXZUVlAwUXVsbHF5U0N0ZDI0Vzlfdkd3Q0JKbldwbXRobl9ucW8tZjJaeTk1dHRJblk2TU
📰 Sud Ouest · 24/03/2026
<a href="https://news.google.com/rss/articles/CBMi_AFBVV95cUxNZHZLLWQzTUUyOVFraWdTX01OOXZpR3pPc3h6U2dvQVhKbllfSS1fbDJJWk9RRXdYVXFlQkltWFhfZ2N5M2tNTU51WGktOXNBRTk1bzJKUmZ1NFdIb0hIQTBQZWFJMXg4Y3NtOFN3ZGlLXzk2aWhJdk5GQXV6Zk5iNFNlOEQzMVY5VlVJVFNjVmJjM2djQXloeERLNlliOFJZYzNQdHdXWW14eEhwTHpVLTFFVTNxUjVuVW
📰 Quidam Hebdo · 12/03/2026
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQM2RsS0JodUdCbnZDcGQyWWVHVXQ4UkluRC1kRGo5LXlwdW16OExxT1U2cEpBcGFjNnhRT010T05sMmJndGJvS2FaMzZ1Mkp0Zko0czcyeEloSXpNM0M5aE05dzlHLVpfdV9ULTJacEJqeGFzR0FTZHJtWUtPNVVWeFBVd2hUZkJjR3pvd2JNZW1Udw?oc=5" target="_blank">Municipales 2026 : une nouvel
📰 Sud Ouest · 06/03/2026
<a href="https://news.google.com/rss/articles/CBMikwJBVV95cUxNbGppZTJmTHhqQ3pidGZpaWhmeXZQb3pyMFMxY2hreWhoLTVOam81ekpXaU1xOEVob0VYbkhEeThwbEVVeVhSSUNqQ3FtWDZqa0M0dC13bUFYNk44c2QtSnlEWjFzN3RuQkNrZFVaZnBPV3VKbXpSRUZNcXdDd1pRQnpzbm9neFZTOGc0VHdZcXVLV1VES1Ffa2tnRmJhTGNKeFFSd0l6T1ZsUW5sbzV4RlFMM3lKY3NWR3
📰 Le Charlevoisien · 18/09/2025
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxObmFIQWc1Y3FxaGdabVR6N1FfSm1rZloyVWtyRXY5NmhYaHFSTUlWWXdVUlNHbFRGVUcxYkMzb2taak1RNHRET3pjUjZWVjJBNVBLaW14QUpTQjRuUWoyRE03cTFYVDAxd2hvdWF3X1JLeDRtZ2JENFZEa3FrSS1tQ0taRWJIQi1yNWJPckYtd3hXRDROdlE?oc=5" target="_blank">Le chantier du Medway Al
📰 Radio-Canada · 23/10/2024
<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQcWphd2xMUUl3UUtmeGh5QUhraTl6WWxQR0MwendWUWtZT3FSajl1allOeC1Wd0FsNmgxaDFnQ1ZKdHBDMUVHMVhNOHVud1RmQlVqWmh2akNmVmZ1T3VrUVo0VTFsSl9xLWFPUDNKN3FmckZUNUp2X2F1cU9NS0NsaE5DZzJLa0ZDR2daMVRWc3JOMlg5ZGY0VTl3RVNrTkhfVmpGcWROVklOTUlQbkY3WA?oc=5" targe
📰 Le Progrès · 21/07/2024
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxQZHdpc1lQblgzN29HeGE3ZkRGZzQ5aU9wek5kem5zX3I5YjFINk5haWwyS01VLU5yWXlVWVc1SDMycWxWNXRSSk9ER2w2Qnc2cTdpdjJRdGF4M1g3c2Q2YzhQdkphLXdkcDZHQVZuaExwZFQtMTZOQWczc0t5a2RkOG53d0N5aFJEcVFwemNGSXdKYThYWDdqckxqa1FVakVITkZXVnhYNHBXQml3ZjA4X3lrMTcyUmdhV2
📰 Allnews · 10/01/2024
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQbnQ4c1h2endJdF9sWjFhTndDNGNjN2F3UkVhMHRaUUtKV0lYeVlFa01GRng3Qk5GbWJNczNGdFh4QXBqMDNneWtiR0NWLXF5SEtCWk5TeGR4ZDBBRGhOVVEwUkRBZmlBeEd2VFFPWnZmSEdBOHNGN2U3ZEZRem85SHh6eUFmZUczazdqVGRqcUZiZkhVSU5Ld0tVNA?oc=5" target="_blank">Un nouvel associé
📰 Capital.fr · 05/07/2019
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxNNXlmcFBGeWNTcDQ1QXl0UlJXV0pYc09WXzJsQ3hrWEdob0JSbUpTako2T0RMUFRlMGxFVUlhdkQySGdDUW1HOU16MXBIc1hNcFVmR2lhcVhnQjlsZ0VnQlFqWDRhLVMyMkY3eFNXRXA4dUFLeE1icUNOQnlIWWxqS2tITkFUY09fUWVzT1FQMmxWTUdkNlJlOTNkZVVHSlpfNmx2Ni1BblJfWHpxbU1uWE1aYzlfSTZ4bV
📰 Ouest-France · 12/01/2008
<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPSTktOFhXbXR1VGsxQXBjdVBvVzNrcThyckFBSTJBNkN3b09VR09MOWtrWEdyUVhTWnZfZjZRQWlpbVoySXdsbG11RFZ4WFVWWkUwR0hQc19PeGUtR3JweS1zVEZBY1QzZGhVUWM2bGhIN1JXeC11OTl6a1QteWdiS0JmTW5rRENkUWQxS2xFZnF2WU5Idjlkd2pNN1liR1BxNkFDbV9hYjA1SlU?oc=5" target="_bla
Frontiers in immunology · 2021
Nonresolving inflammation is a critical driver of several chronic inflammatory diseases, including inflammatory bowel diseases (IBD). This unresolved inflammation may result from the persistence of an initiating stimulus or from the alteration of the resolution phase of inflammation. Elimination of apoptotic cells by macrophages (a process called efferocytosis) is a critical step in the resolution phase of inflammation. Efferocytosis participates in macrophage reprogramming and favors the release of numerous pro-resolving factors. These pro-resolving factors exert therapeutic effects in experimental autoimmune arthritis. Here, we propose to evaluate the efficacy of pro-resolving factors produced by macrophages after efferocytosis, a secretome called SuperMApo, in two IBD models, namely dextran sodium sulfate (DSS)-induced and T cell transfer-induced colitis. Reintroducing these pro-resolving factors was sufficient to decrease clinical, endoscopic and histological colitis scores in ongoing naive T cell-transfer-induced colitis and in DSS-induced colitis. Mouse primary fibroblasts isolated from the colon demonstrated enhanced healing properties in the presence of SuperMApo, as attested by their increased migratory, proliferative and contractive properties. This was confirmed by the use of human fibroblasts isolated from patients with IBD. Exposure of an intestinal epithelial cell (IEC) line to these pro-resolving factors increased their proliferative properties and IEC acquired the capacity to capture apoptotic cells. The improvement of wound healing properties induced by SuperMApo was confirmed in vivo in a biopsy forceps-wound colonic mucosa model. Further in vivo analysis in naive T cell transfer-induced colitis model demonstrated an improvement of intestinal barrier permeability after administration of SuperMApo, an intestinal cell proliferation and an increase of α-SMA expression by fibroblasts, as well as a reduction of the transcript coding for fibronectin (Fn1). Finally, we identified TGF-β, IGF-I and VEGF among SuperMApo as necessary to favor mucosal healing and confirmed their role both in vitro (using neutralizing antibodies) and in vivo by depleting these factors from efferocytic macrophage secretome using antibody-coated microbeads. These growth factors only explained some of the beneficial effects induced by factors released by efferocytic macrophages. Overall, the administration of pro-resolving factors released by efferocytic macrophages limits intestinal inflammation and enhance tissue repair, which represents an innovative treatment of IBD.
Journal of clinical medicine · 2019
Objectives: Th1.17 are highly polyfunctional, potentially harmful CD4+ effector T cells (Teff) through IFN-γ and IL-17A coproduction. Th1.17 take part in the pathophysiology of rheumatoid arthritis (RA) and psoriatic arthritis (PsA), in which their hyper activation results in part from defects in negative regulation mechanisms. We recently demonstrated that the ecto-nucleotidase CD73 delineates a Th1.17-enriched Teff population and acts as an endogenous regulatory mechanism. Because Methotrexate (MTX), used as first line treatment of RA and PsA, increases extracellular concentrations of AMP and immunosuppressive adenosine, we investigated the modulation of CD73 by MTX treatment on Teff in RA/PsA patients. Methods: In a prospective cohort of 26 RA and 15 PsA patients before or under MTX treatment, we evaluated CD73 expression on blood Teff subsets, their cytokine production and AMPase functions. Results: We showed a decreased CD73 expression on Th1.17 and Th1 in untreated patients compared to healthy donors that was partly restored under MTX. This decrease in untreated patients leads to a halved Ado production by Th1.17 cells. CD73+ Teff remained functional under MTX treatment, but their CD73 re-expression may contribute to control their activation. Conclusion: Our study unveils uncovered mode of action of MTX on Teff subsets modulation and in the adenosine-dependent termination of inflammation in RA and PsA.
Rheumatology international · 2016
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Frontiers in immunology · 2021 · Journal Article
Martin-Rodriguez O, Gauthier T, Bonnefoy F, Couturier M, et al.
La Revue de medecine interne · 2018 · Case Reports
Guiot A, Couturier M, Tebib JG, Abouaf L, et al.
Rheumatology international · 2016 · Journal Article
Couturier M, Arbault A, Laroche D, Contant E, et al.
Journal of clinical medicine · 2019 · Journal Article
Bossennec M, Rodriguez C, Hubert M, Di-Roio A, et al.
✨ Profil synthétique
IA · 25/05/2026Le Dr Michel Couturier est un rhumatologue avec une production scientifique diversifiée, mais dont les publications PubMed sont notamment axées sur les csDMARDs. Son h-index est de 6, avec 28 publications. Ses recherches semblent également toucher à des domaines non médicaux, tels que la technologie musicale et les interactions sensorielles.
Expertises présumées
Synthèse automatique à partir des sources publiques (HAL, OpenAlex, theses.fr, ClinicalTrials.gov, FAI²R, ANS). Pas une évaluation clinique. Le médecin peut corriger via son compte.